Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash Flows from Operating Activities:
Net income	$ 8,715	$ 9,357
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,003	1,874
Amortization on right-of-use assets	1,656
Provision for bad debts	(978)	(593)
Deferred income tax - net	1,816	2,341
Stock issued for costs and expenses	1,990	1,955
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivable(s)	(4,300)	(2,309)
Notes receivable	11	(13)
Costs and estimated earnings in excess of billings on uncompleted contracts	372
Inventories	47	(225)
Prepaid expenses and other current assets	330	304
Other assets	(45)	2
Increase (decrease) in operating liabilities, net:
Accounts payable	(576)	(6)
Other current liabilities	430	(3,003)
Operating lease liabilities	(1,447)
Customer deposits	28	71
Billings in excess of costs and estimated earnings on uncompleted contracts	12
Other liabilities	123	21
Due to related party medical practices		(135)
Net cash provided by operating activities	10,187	9,641
Cash Flows from Investing Activities:
Purchases of property and equipment	(4,656)	(2,238)
Short term investment	(199)
Cost of patents	(62)	(45)
Net cash used in investing activities	(4,917)	(2,283)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(24)	(15)
Distributions to noncontrolling interests	(3,735)	(3,690)
Net cash used in financing activities	(3,759)	(3,705)
Net Increase (decrease) in Cash and Cash Equivalents	1,511	3,653
Cash and Cash Equivalents - Beginning of Period	13,882	19,634
Cash and Cash Equivalents - End of Period	$ 15,393	$ 23,287